Mastek Limited — Investor Meet, 25-04-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Mastek Limited reported a 13.1% increase in revenue for the fiscal year 2025, reaching INR 1,792 crores, and a net profit growth of 20.9%, totaling INR 261 crores. While the U.K. business demonstrated robust performance with a year-on-year revenue growth of 17.2%, overall profitability faced challenges, with EBITDA declining by 1.4% and net profit decreasing by 14.4% in Q4. This decline is attributed to higher operational costs linked to new service offerings in Data & AI and adjustments following organizational restructuring.

**Future Outlook and Growth Drivers:** Management remains optimistic about sustained growth in the U.K. and Europe, especially in the healthcare sector and secured government services. Focus on Data & AI is projected to drive significant advancements. The company aims to acquire new projects and secure various government contracts.

**Order Book and Operational Updates:** The 12-month order backlog showed a modest 1.7% increase, with a significant $15 million contract set to contribute to this backlog reported early in the new fiscal year. The secured government services sector is anticipated to provide stable growth in the coming years.

**Analyst Q&A Insights:** Analysts expressed concerns about margin trends, particularly in the U.K., with management indicating that initial business in Data & AI, while promising, comes with lower margins. The transition in North America was highlighted, where macroeconomic uncertainties have caused some delays and budget cuts, prompting a reevaluation of strategies.

**Market or Regulatory Updates:** Management noted ongoing changes in public sector funding impacting project timelines but indicated no immediate threats to current healthcare-related contracts.

**Strategic Focus Areas:** A notable strategic pivot towards innovative and efficient technology adoption, specifically AI, is emphasized. Operational efficiency and restructuring efforts continue to be crucial in navigating short-term challenges.

**Investor Insight:** The solid growth trajectory in key sectors, improved cash reserves, and the strategic focus on operational efficiencies present a favorable outlook. Given the operational adjustments and market potential, the financial health and growth narrative suggest a 'buy' position for investors.